Your browser doesn't support javascript.
loading
Incidence and Outcomes of New-Onset Right Bundle Branch Block Following Transcatheter Aortic Valve Replacement.
Tan, Nicholas Y; Adedinsewo, Demilade; El Sabbagh, Abdallah; Sayed Ahmed, Ahmed F; Carolina Morales-Lara, Andrea; Wieczorek, Mikolaj; Madhavan, Malini; Mulpuru, Siva K; Deshmukh, Abhishek J; Asirvatham, Samuel J; Eleid, Mackram F; Friedman, Paul A; Cha, Yong-Mei; Killu, Ammar M.
Afiliación
  • Tan NY; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Adedinsewo D; Department of Cardiovascular Medicine (D.A., A.E.S., A.F.S.A., A.C.M.-L.).
  • El Sabbagh A; Department of Cardiovascular Medicine (D.A., A.E.S., A.F.S.A., A.C.M.-L.).
  • Sayed Ahmed AF; Department of Cardiovascular Medicine (D.A., A.E.S., A.F.S.A., A.C.M.-L.).
  • Carolina Morales-Lara A; Department of Cardiovascular Medicine (D.A., A.E.S., A.F.S.A., A.C.M.-L.).
  • Wieczorek M; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL (M.W.).
  • Madhavan M; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Mulpuru SK; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Deshmukh AJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Asirvatham SJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Eleid MF; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Friedman PA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Cha YM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
  • Killu AM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.Y.T., M.M., S.K.M., A.J.D., S.J.A., M.F.E., P.A.F., Y.-M.C., A.M.K.).
Circ Arrhythm Electrophysiol ; 17(2): e012377, 2024 02.
Article en En | MEDLINE | ID: mdl-38288627
ABSTRACT

BACKGROUND:

The incidence and prognosis of right bundle branch block (RBBB) following transcatheter aortic valve replacement (TAVR) are unknown. Hence, we sought to characterize the incidence of post-TAVR RBBB and determine associated risks of permanent pacemaker (PPM) implantation and mortality.

METHODS:

All patients 18 years and above without preexisting RBBB or PPM who underwent TAVR at US Mayo Clinic sites and Mayo Clinic Health Systems from June 2010 to May 2021 were evaluated. Post-TAVR RBBB was defined as new-onset RBBB in the postimplantation period. The risks of PPM implantation (within 90 days) and mortality following TAVR were compared for patients with and without post-TAVR RBBB using Kaplan-Meier analysis and Cox proportional hazards modeling. The risks of PPM implantation (within 90 days) and mortality following TAVR were compared for patients with and without post-TAVR RBBB using Kaplan-Meier analysis and Cox proportional hazards modeling.

RESULTS:

Of 1992 patients, 15 (0.75%) experienced new RBBB post-TAVR. There was a higher degree of valve oversizing among patients with new RBBB post-TAVR versus those without (17.9% versus 10.0%; P=0.034). Ten patients (66.7%) with post-TAVR RBBB experienced high-grade atrioventricular block and underwent PPM implantation (median 1 day; Q1, 0.2 and Q3, 4), compared with 268/1977 (13.6%) without RBBB. Following propensity score adjustment for covariates (age, sex, balloon-expandable valve, annulus diameter, and valve oversizing), post-TAVR RBBB was significantly associated with PPM implantation (hazard ratio, 8.36 [95% CI, 4.19-16.7]; P<0.001). No statistically significant increase in mortality was seen with post-TAVR RBBB (hazard ratio, 0.83 [95% CI, 0.33-2.11]; P=0.69), adjusting for age and sex.

CONCLUSIONS:

Although infrequent, post-TAVR RBBB was associated with elevated PPM implantation risk. The mechanisms for its development and its clinical prognosis require further study.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estenosis de la Válvula Aórtica / Marcapaso Artificial / Prótesis Valvulares Cardíacas / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circ Arrhythm Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estenosis de la Válvula Aórtica / Marcapaso Artificial / Prótesis Valvulares Cardíacas / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circ Arrhythm Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article